“Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies” — Jennifer A. Doudna Copy Share Image
“we founded Editas Medicine with $43 million in financing from three venture capital firms.” — Jennifer A. Doudna Copy Share Image
